Pharmaceuticals Financial News

Bank Nifty was up by 91.15(0.19%) at 05 Apr 2024 10:44:53 IST.In the BSE Sensex index HDFC Bank, Mahindra & Mahindra, Kotak Mahindra Bank, NTPC, State Bank Of India were the top gainers while Larsen & Toubro, Bajaj Finance, Ultratech Cement, Tech Mahindra, Axis Bank were the top losers.In the Bank Nifty index Au Small Finance Bank, HDFC Bank, Punjab National Bank, Bandhan Bank, Kotak Mahindra Bank were the top gainers while Axis Bank, ICICI Bank, Indusind Bank, were the top losers.For the complete list of 52 week high stocks click here. Milestone Alert! Livemint tops charts as the fastest growing news website in the world

“Market valuations would be one of the key risks for Indian markets, which could lead it to give relatively subdued returns in FY25,” says Sampath Reddy, Chief Investment Officer, Bajaj Allianz Life. In an interview with ETMarkets, Reddy said: “We remain optimistic on the 1) pharmaceutical sector, particularly companies involved in exports of generic medicines on the back of improved pricing environment in the key US market,”. Edited excerpts: We have closed FY24 with double-digit gains. How do you see markets in FY25? Sampath Reddy: The Indian equity markets have fared well in FY24 and have been one of the top-performing markets over the medium to long term as well.

The maker of a drug for Lou Gehrig’s disease that recently failed in a study says it will pull the medicine from the U.S. market

₹1.97 trillion (over $26 billion) to support manufacturing growth in 14 sectors, especially those that help in import substitution such as specialty steel and drone components. The outlay was for a period of five years starting 2022.

The fund's exposure to Danish pharmaceutical firm Zealand Pharma A/S hit 12.1%, according to its February factsheet, surpassing the 10% limit imposed on UCITS vehicles. Four Graphs explaining silver Zealand Pharma is involved in the production and design of diabetes and obesity medications, a corner of the healthcare market which has seen a huge surge in investment in the wake of Novo Nordisk's Ozempic medication becoming a cult product for weight loss. The company's shares had historically traded at around 200 DKK (£22.92) per share, but last month it experienc...

Sanofi India Ltd.(up 1.57 per cent), Laurus Labs Ltd.(up 1.36 per cent), Natco Pharma Ltd.(up 1.22 per cent), Zydus Lifesciences Ltd.(up 0.84 per cent) and Abbott India Ltd.(up 0.45 per cent) were among the top gainers.

Aurobindo Pharma on Monday said it has commissioned four state-of-the-art manufacturing facilities for Penicillin-G, 6-Amino Penicillanic Acid (6-APA), Injectable products and Granulation, through its wholly owned subsidiaries. Penicillin-G (Pen-G) facility, located in a SEZ at Kakinada in Andhra Pradesh, has a production capacity of 15,000 tonne per annum and also 1.8 lakh tonne of gulcose, while 6-Amino Penicillanic Acid plant has a capacity to produce 3,600 tonne annually, the drug maker said in a press release. The Rs 2,400 crore Pen-G plant is expected to start trial production in April and commercial production in a couple of months and the ramping up of the production will happen during the second quarter of the current fiscal, a senior official of the city-based drug maker had earlier said. The plant was approved under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country.

India and Uzbekistan. Ambassador Sardor Rustambaev, who previously led the diplomatic mission of Uzbekistan in France and Portugal and recently took over as the head of mission in India, spoke exclusively to ET. How would you characterize India-Uzbekistan strategic partnership?

Japanese government health officials are raiding a factory that produces health supplements they say have killed at least five people and hospitalized more than 100 others

In the week since a line of Japanese health supplements began being recalled, five people have died and more than 100 people are hospitalized

block deals worth Rs 16,624 crore which included both buying and selling action. In the largecap segment, 15 companies witnessed significant block deals that were worth Rs 8,026 crore led by Mankind Pharma which saw equity worth Rs 2,639 crore changing hands. The next in line were IndusInd Bank (Rs 895 crore), Axis Bank (Rs 816 crore), HDFC Life Insurance (Rs 614 crore), Reliance Industries (Rs 570 crore), State Bank of India (Rs 548 crore), Mahindra & Mahindra (Rs 348 crore), and Kotak Mahindra Bank (Rs 243 crore).

Bank Nifty was up by 502.6(1.07%) at 28 Mar 2024 10:44:53 IST.In the BSE Sensex index Bajaj Finserv, Bajaj Finance, State Bank Of India, Ultratech Cement, ICICI Bank were the top gainers while HCL Technologies, Titan Company, were the top losers.In the Bank Nifty index ICICI Bank, State Bank Of India, Bank Of Baroda, HDFC Bank, Indusind Bank were the top gainers while IDFC First Bank, Bandhan Bank, Federal Bank, were the top losers.For the complete list of 52 week high stocks click here. Milestone Alert! Livemint tops charts as the fastest growing news website in the world

Health supplement products believed to have caused two deaths and sickened more than 100 people have been ordered to be taken off store shelves in Japan

final round of talks on a landmark pandemic accord faces a frantic last push this week, with countries still pulling in different directions on how to handle future global health crises. The last week of negotiations runs until Thursday with nations trying to hammer out an agreement to make sure the world is better prepared to deal with the next pandemic — or better still, stamp it out before it even happens.

Dalal Street – smallcap stocks – as we saw as many as 181 of them turning multibaggers. What’s worth noting is that more than 100 of these smallcap stocks went through a bad phase in the preceding financial year. So, FY24 became a turnaround year for many of them.

pandemic accord faces a frantic last push this week, with countries still pulling in different directions on how to handle future global health crises. The last week of negotiations runs until Thursday with nations trying to hammer out an agreement to make sure the world is better prepared to deal with the next pandemic — or better still, stamp it out before it even happens.

Biotech startup Loyal has raised $45 million in equity to help bring its first longevity drug for dogs to market. Bain Capital Ventures led the Series B financing, with participation by new backer Valor Equity Partners, as well as returning investors Khosla Ventures, First Round Capital and others. Bain Partner Kevin Zhang has joined Loyal’s board.

Spicejet and Tech Mahindra were among those who donated to the Aam Aadmi Party through electoral bonds, according to Election Commission data made public on Thursday. The Election Commission made public a fresh data set of electoral bonds, including their alpha-numeric numbers that can help match their purchasers with the political parties that received the funds. Megha Engineering And Infrastructures Limited, Torrent Pharmaceuticals Limited, BG Shirke Construction Technology Pvt Ltd, Bajaj Auto Ltd, Tech Mahindra Ltd, Spicejet Limited, Derive Trading And Resorts Private Limit, Vardhman Textiles Ltd and V M Salgaocar Corporation Pvt Ltd were among the major companies that donated electoral bonds to the party.

global demand for Indian goods despite the Red Sea crisis, which attracted military response from several countries, impacting trade. Outstanding export credit for Indian banks was seen at Rs 20489 crore at the end of January 26, rising 5% this financial year, data from Reserve Bank of India showed. This was the highest since February last year. «Export growth will be largely driven by global demand and as we do expect global growth to be steady, we can expect a recovery here. This will be reflected also in growth in export credit,» Bank of Baroda chief economist Madan Sabnavis said.

Shares of Aurobindo Pharma Ltd.(up 2.72 per cent), GlaxoSmithKline Pharmaceuticals Ltd.(up 2.38 per cent), Glenmark Pharmaceuticals Ltd.(up 2.25 per cent), Ipca Laboratories Ltd.(up 1.47 per cent) and Torrent Pharmaceuticals Ltd.(up 0.7 per cent) ended the day as top gainers in the pack.

Stocks that traded heavily or had substantial price changes on Tuesday: International Paper, Unilever rise; Super Micro, Freeport-McMoRan fall